{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:47:13Z","timestamp":1782514033513,"version":"3.54.5"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T00:00:00Z","timestamp":1500336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1093\/europace\/eux203","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T07:33:50Z","timestamp":1500363230000},"page":"897-901","source":"Crossref","is-referenced-by-count":36,"title":["Do women benefit equally as men from the primary prevention implantable cardioverter-defibrillator?"],"prefix":"10.1093","volume":"20","author":[{"given":"S\u00e9rgio","family":"Barra","sequence":"first","affiliation":[{"name":"Cardiology Department, Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridge CB23\u20093RE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Provid\u00eancia","sequence":"additional","affiliation":[{"name":"Cardiology Department, Barts Heart Centre, Barts Health NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Boveda","sequence":"additional","affiliation":[{"name":"Cardiology Department, Clinique Pasteur, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Narayanan","sequence":"additional","affiliation":[{"name":"Cardiology Department, Maxcure Hospitals, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munmohan","family":"Virdee","sequence":"additional","affiliation":[{"name":"Cardiology Department, Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridge CB23\u20093RE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloi","family":"Marijon","sequence":"additional","affiliation":[{"name":"Paris Cardiovascular Research Center, Paris, France"},{"name":"Paris Descartes University, Paris, France"},{"name":"Cardiology Department, European Georges Pompidou Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Cardiology Department, Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridge CB23\u20093RE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,18]]},"reference":[{"key":"key\n\t\t\t\t20180601072922_eux203-B1","first-page":"1601","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180601072922_eux203-B2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1540-8167.2008.01129.x","article-title":"Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial","volume":"19","author":"Russo","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key\n\t\t\t\t20180601072922_eux203-B3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1053\/hj.1998.v136.90226","article-title":"Sudden coronary death in women","volume":"136","author":"Kannel","year":"1998","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180601072922_eux203-B4","doi-asserted-by":"crossref","first-page":"e002398.","DOI":"10.1161\/JAHA.115.002398","article-title":"Lifetime risk for sudden cardiac death in the community","volume":"5","author":"Bogle","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20180601072922_eux203-B5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jacc.2010.06.061","article-title":"Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial","volume":"57","author":"Arshad","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180601072922_eux203-B6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/heartjnl-2016-310677","article-title":"Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure","volume":"103","author":"Barra","year":"2017","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180601072922_eux203-B7","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/CIRCULATIONAHA.110.940148","article-title":"Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II","volume":"122","author":"Goldenberg","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180601072922_eux203-B8","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/archinternmed.2009.255","article-title":"Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials","volume":"169","author":"Ghanbari","year":"2009","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20180601072922_eux203-B9","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2015-307634","article-title":"Individual patient data network meta-analysis of mortality effects of implantable cardiac devices","volume":"101","author":"Woods","year":"2015","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180601072922_eux203-B10","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehl099","article-title":"Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180601072922_eux203-B11","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehx028","article-title":"Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials","author":"Shun-Shin","year":"2017","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180601072922_eux203-B12","doi-asserted-by":"crossref","first-page":"195.","DOI":"10.7326\/0003-4819-156-3-201202070-00007","article-title":"Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database","volume":"156","author":"MacFadden","year":"2012","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180601072922_eux203-B13","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1161\/CIRCULATIONAHA.111.069245","article-title":"Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator","volume":"126","author":"Rho","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180601072922_eux203-B14","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1161\/CIRCULATIONAHA.114.011283","article-title":"Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy","volume":"130","author":"Ruwald","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180601072922_eux203-B15","doi-asserted-by":"crossref","first-page":"e002539","DOI":"10.1161\/JAHA.115.002539","article-title":"Importance of implantable cardioverter-defibrillator back-up in cardiac resynchronization therapy recipients: a systematic review and meta-analysis","volume":"4","author":"Barra","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20180601072922_eux203-B16","article-title":"Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator: a systematic review and proportional meta-analysis","author":"Barra","year":"2017","journal-title":"Europace"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/20\/6\/897\/24978189\/eux203.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T15:04:54Z","timestamp":1569855894000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/20\/6\/897\/3978741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,18]]},"references-count":16,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,7,18]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/eux203","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2017,7,18]]}}}